Matrixyl Neolide uses patented encapsulation technology to ensure over 15 days of peptide release and measured gains in skin firmness within two weeks.
Matrixyl Neolide, presented by Croda Beauty Actives, is based on a patented encapsulation that protects the peptide in the formulation and controls its release into the skin - the company reports a prolonged release of +15 days.
Encapsulation and release kinetics
The claimed encapsulation guarantees stability and controlled release of the peptide, according to the technical description. Croda Beauty Actives highlights the possibility of designing formulas with fewer «formulation noise» and increased performance stability.
Clinical results and professional application
Initial clinical data show an improvement in skin firmness of +25 % at two weeks (p<0.01 vs T0). Croda Beauty Actives also reported a +31 % increase in collagen III in a protocol combining the active with microneedling (p<0.01 vs placebo + microneedling).
The formulation boasts 99.79 % of natural-origin content according to ISO 16128 and a carbon footprint reduction of -43 % compared to Matrixyl, as well as TFAs-free, Rspo and vegan compatibility.
The new offer is positioned to fit into professional routines and recovery treatments after light aesthetic procedures, with a promise of sustained activity over time.
